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Introduction: The ‘Amyloid Hypothesis’ suggests that the build-up of (Aȕ) is a 
primary causal event in Alzheimer’s disease. Aȕ is cleaved from amyloid 
precursor protein (APP) by the ȕ- and Ȗ- secretases, all of which have been 
identified in lipid raft-regions of the plasma membrane. Caveolae are specialised 
forms of lipid rafts, enriched with caveolin proteins.  We examined whether 
expression of the most ubiquitous caveolin protein, caveolin-1, could affect the 
processing of APP into Aȕ. 
Methods: Levels of caveolin-1 in astrocytoma cells were depleted by siRNA or 
over-expressed by delivering constructs carrying the myc-tagged caveolin-1 gene 
to these cells.  Cells were lysed and media collected to detect intra- and 
extracellular protein levels of lipid raft proteins, APP and APP metabolites 
including Aȕ.  
Results: After caveolin-1 levels were reduced by siRNA APP levels were 
unaffected, however, expression levels of Aȕ were significantly increased. 
Conversely, after over-expression of caveolin-1, APP levels were significantly 
reduced and expression levels of Aȕ were unchanged. 
Conclusion: These results suggest that at normal physiological levels, 
caveolin-1 has a regulatory effect on Aȕ and may provide a novel therapeutic 
target for this disease. 
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